Obstructive Sleep Apnea Syndrome: Pathogenesis, Treatments and Comorbidity
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: closed (31 March 2021) | Viewed by 24276
Special Issue Editor
Interests: autonomic nervous system (ASN); hypothalamus–pituitary–adrenal (HPA) axis; cortisol; α-amylase; obstructive sleep apnea (OSA); central serous chorioretinopathy (CSC); menopause; salivary biomarkers of stress
Special Issue Information
Dear Colleagues,
Obstructive Sleep Apnea (OSA) is a common health problem characterized by repeated apneic events during sleep, resulting from a mechanical obstruction due to a decreased muscle tone of the upper airway. The OSA syndrome includes, among others symptoms, the occurrence of excessive daytime sleepiness due to poor quality sleep. Although continuous positive airway pressure is considered the treatment of choice, suboptimal acceptance and progressively reduced adherence rates can limit its efficacy. Therefore, several studies focused on the identification of the causes that could justify the nonadherence of some subjects to the prescribed therapeutic approach, evaluating their psychosocial behavior and personality traits.
As a whole, OSA can be considered a multifactorial disease; indeed, a multidisciplinary approach might be the best option to deepen the pathogenetic aspects of a syndrome that sees juxtaposed researchers from different medical specialties: internists, pulmonologists, cardiologists, ophthalmologists, otolaryngologists, clinical pharmacologists, psychologists, and nutritionists.
This Special Issue has the ambitious goal of highlighting how multidisciplinary approaches can contribute to the improvement of knowledge on the pathogenetic mechanisms of OSA and related comorbidities, therefore, with the aim of improving the quality of life of the subjects affected by OSA and also to suggest preventive interventions and care.
Prof. Dr. Francesca Romana Patacchioli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- obstructive sleep apnea
- ocular diseases
- behavioral medicine
- cardiometabolic risk
- biomarkers
- nasal disease
- novel therapy